• LAST PRICE
    11.8000
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-0.1692%)
  • Bid / Lots
    11.4800/ 1
  • Ask / Lots
    12.0800/ 3
  • Open / Previous Close
    11.7900 / 11.8200
  • Day Range
    Low 11.6750
    High 12.1000
  • 52 Week Range
    Low 4.2000
    High 15.1800
  • Volume
    98,806
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 11.82
TimeVolumeVSTM
09:32 ET79811.95
09:50 ET105011.78
09:56 ET234211.85
10:03 ET10011.7813
10:06 ET60011.845
10:10 ET10011.78
10:14 ET93311.875
10:15 ET10011.89
10:17 ET20011.96
10:21 ET10011.98
10:30 ET57511.9
10:35 ET160012
10:37 ET70711.982
10:39 ET234612
10:44 ET10012
10:50 ET10012
10:51 ET100012
10:53 ET120012
10:55 ET19212
11:00 ET30011.95
11:20 ET308212
11:22 ET196812
11:27 ET93512.012
11:31 ET50012.035
11:40 ET202112.1
11:42 ET487812.07
11:56 ET10012.0525
11:58 ET18612.07
12:00 ET10012.035
12:03 ET10012.04
12:09 ET99812
12:16 ET10012.02
12:21 ET20011.9412
12:23 ET10011.98
12:36 ET10012.05
12:43 ET20011.99
12:50 ET20012.04
12:52 ET72811.9845
12:54 ET10011.98
01:06 ET10012.045
01:17 ET40012.025
01:19 ET60012.025
01:32 ET10011.985
01:33 ET10011.985
01:37 ET20011.9
01:48 ET10011.955
01:57 ET10011.95
02:00 ET20011.86
02:02 ET10011.9
02:06 ET50011.855
02:13 ET70011.94
02:20 ET10011.93
02:22 ET80711.9
02:26 ET19611.89
02:31 ET10011.92
02:36 ET10011.95
02:38 ET260011.88
02:54 ET40011.9
03:00 ET30011.97
03:02 ET18411.9485
03:03 ET10011.94
03:05 ET30011.93
03:12 ET10011.91
03:14 ET20011.9
03:16 ET10011.955
03:27 ET86711.92
03:30 ET70011.88
03:34 ET50011.87
03:41 ET10011.84
03:43 ET10011.86
03:48 ET213911.79
03:52 ET109611.82
03:54 ET20011.84
03:56 ET130911.84
03:57 ET40011.84
03:59 ET50011.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVSTM
Verastem Inc
299.0M
-2.9x
---
United StatesATAI
ATAI Life Sciences NV
297.2M
-4.3x
---
United StatesFENC
Fennec Pharmaceuticals Inc
299.7M
-14.6x
---
United StatesINO
Inovio Pharmaceuticals Inc
304.5M
-2.3x
---
United StatesRAPT
RAPT Therapeutics Inc
310.7M
-2.9x
---
United StatesERAS
Erasca Inc
311.2M
-2.5x
---
As of 2024-03-28

Company Information

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).

Contact Information

Headquarters
117 Kendrick Street, Suite 500CAMBRIDGE, MA, United States 02494
Phone
781-292-4200
Fax
302-655-5049

Executives

President, Chief Executive Officer, Director
Daniel Paterson
Chief Financial Officer, Controller
Daniel Calkins
Lead Independent Director
Michael Kauffman
Director
Robert Gagnon
Director
Brian Stuglik

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$299.0M
Revenue (TTM)
$0.00
Shares Outstanding
25.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.48
EPS
$-4.07
Book Value
$3.11
P/E Ratio
-2.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.